Cardlytics Valuation
| CDLX Stock | USD 12.22 0.28 2.35% |
At this time, the firm appears to be fairly valued. Cardlytics shows a prevailing Real Value of $12.61 per share. The current price of the firm is $12.22. Our model approximates the value of Cardlytics from analyzing the firm fundamentals such as Return On Equity of -0.78, profit margin of (0.44) %, and Current Valuation of 713.29 M as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend. Key fundamental drivers impacting Cardlytics' valuation include:
Price Book 4.4404 | Enterprise Value 713.3 M | Enterprise Value Ebitda (7.81) | Price Sales 1.9358 | Enterprise Value Revenue 2.4994 |
Fairly Valued
Today
Please note that Cardlytics' price fluctuation is unstable at this time. Calculation of the real value of Cardlytics is based on 3 months time horizon. Increasing Cardlytics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Cardlytics is useful when determining the fair value of the Cardlytics stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Cardlytics. Since Cardlytics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cardlytics Stock. However, Cardlytics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 12.22 | Real 12.61 | Target 17.0 | Hype 12.22 |
The real value of Cardlytics Stock, also known as its intrinsic value, is the underlying worth of Cardlytics Company, which is reflected in its stock price. It is based on Cardlytics' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Cardlytics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cardlytics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Cardlytics helps investors to forecast how Cardlytics stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cardlytics more accurately as focusing exclusively on Cardlytics' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Cardlytics' intrinsic value based on its ongoing forecasts of Cardlytics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Cardlytics' closest peers. When choosing an evaluation method for Cardlytics, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Cardlytics Investments |
|
Cardlytics Valuation Trend
Knowing Cardlytics' actual value is paramount for traders to make sound investment determinations. Cardlytics' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Cardlytics' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Cardlytics' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Cardlytics Market Cap
Cardlytics is number one stock in market capitalization category among related companies. Market capitalization of Communication Services industry is currently estimated at about 603.37 Million. Cardlytics totals roughly 588.69 Million in market capitalization claiming about 98% of stocks in Communication Services industry.Cardlytics Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Cardlytics's current stock value. Our valuation model uses many indicators to compare Cardlytics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cardlytics competition to find correlations between indicators driving Cardlytics's intrinsic value. More Info.Cardlytics is rated fourth in price to earning category among related companies. It is number one stock in price to book category among related companies . Price To Book Ratio is likely to rise to 3.76 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value Cardlytics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cardlytics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cardlytics' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cardlytics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cardlytics and how it compares across the competition.
About Cardlytics Valuation
The stock valuation mechanism determines the current worth of Cardlytics on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Cardlytics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Cardlytics based exclusively on its fundamental and basic technical indicators. By analyzing Cardlytics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Cardlytics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cardlytics. We calculate exposure to Cardlytics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cardlytics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 132.2 M | 80.8 M | |
| Pretax Profit Margin | (0.44) | (0.46) | |
| Operating Profit Margin | (0.21) | (0.22) | |
| Net Loss | (0.44) | (0.46) | |
| Gross Profit Margin | 0.43 | 0.30 |
8 Steps to conduct Cardlytics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Cardlytics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Cardlytics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Cardlytics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Cardlytics' revenue streams: Identify Cardlytics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Cardlytics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Cardlytics' growth potential: Evaluate Cardlytics' management, business model, and growth potential.
- Determine Cardlytics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Cardlytics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Cardlytics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Cardlytics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 36.5 M | |
| Quarterly Earnings Growth Y O Y | -0.567 |
Cardlytics Current Valuation Indicators
Valuation refers to the process of determining the present value of Cardlytics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Cardlytics we look at many different elements of the entity such as Cardlytics's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Cardlytics' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Cardlytics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Cardlytics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Cardlytics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Cardlytics' worth.When determining whether Cardlytics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardlytics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardlytics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardlytics Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Cardlytics Stock analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Cardlytics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardlytics. If investors know Cardlytics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardlytics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.57) | Earnings Share (3.69) | Revenue Per Share 8.474 | Quarterly Revenue Growth 0.081 | Return On Assets (0.06) |
The market value of Cardlytics is measured differently than its book value, which is the value of Cardlytics that is recorded on the company's balance sheet. Investors also form their own opinion of Cardlytics' value that differs from its market value or its book value, called intrinsic value, which is Cardlytics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardlytics' market value can be influenced by many factors that don't directly affect Cardlytics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardlytics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardlytics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardlytics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.